Participated · Equity · Oct 2021

Wefight has developed Vik, a virtual assistant and a framework used to build more than a dozen condition-specific apps (depression, asthma, multiple cancers, etc.). The company builds its technology in-house, including natural-language processing and the app framework, and its content is written by professional pharmacists. Vik interprets patient questions, searches a knowledge database, and relays neutral, informative answers so users need not wait for their next doctor appointment. More than 400,000 people have used the service, Vik has delivered 5 million answers, and Wefight employs about 70 people. The company finances new apps by working with pharmaceutical companies as top-of-funnel content partners while retaining editorial independence. Following an $11.6 million (€10 million) funding round, Wefight plans international expansion with a new office in Berlin and will hire local health professionals and partner with patient organizations in each new market. WeFight has developed Vik, a virtual assistant that converses via instant messaging, web chat and SMS to support patients with cancer and other chronic diseases. Contents are written by health professionals and Vik provides advice, daily support, and a channel for patients to share experiences and learn to manage their conditions. Clients include hospitals, pharmaceutical companies and insurers, and the company says Vik is available for conditions including breast cancer, asthma, migraine and depression. WeFight aims to empower patients, prevent relapses, and increase efficiency for healthcare teams by freeing caregivers to focus on complex cases. Founded in 2017 by Benoît Brouard and Pierre Nectoux, the company was a winner of the EIT Health France Innovation Journey pitch contest. With €1.8 million in new funding, WeFight plans to accelerate development of Vik to cover more than 30 diseases by 2020 and to expand into European and North American markets.